163 related articles for article (PubMed ID: 24019906)
1. The CD44(high) tumorigenic subsets in lung cancer biospecimens are enriched for low miR-34a expression.
Basak SK; Veena MS; Oh S; Lai C; Vangala S; Elashoff D; Fishbein MC; Sharma S; Rao NP; Rao D; Phan R; Srivatsan ES; Batra RK
PLoS One; 2013; 8(9):e73195. PubMed ID: 24019906
[TBL] [Abstract][Full Text] [Related]
2. Distinct roles of miR-34 family members on suppression of lung squamous cell carcinoma.
Sun D; Wu Y; Zhang S; Han Y; Shen J; Zheng W; Wei L; Liu Y; Ren L; Gu Z; Liu Y; Liu S; Ding C
Biomed Pharmacother; 2021 Oct; 142():111967. PubMed ID: 34467896
[TBL] [Abstract][Full Text] [Related]
3. miRNA-34a suppresses cell proliferation and metastasis by targeting CD44 in human renal carcinoma cells.
Yu G; Li H; Wang J; Gumireddy K; Li A; Yao W; Tang K; Xiao W; Hu J; Xiao H; Lang B; Ye Z; Huang Q; Xu H
J Urol; 2014 Oct; 192(4):1229-37. PubMed ID: 24866595
[TBL] [Abstract][Full Text] [Related]
4. Decreased expression of cell adhesion genes in cancer stem-like cells isolated from primary oral squamous cell carcinomas.
Mishra A; Sriram H; Chandarana P; Tanavde V; Kumar RV; Gopinath A; Govindarajan R; Ramaswamy S; Sadasivam S
Tumour Biol; 2018 May; 40(5):1010428318780859. PubMed ID: 29888653
[TBL] [Abstract][Full Text] [Related]
5. Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma.
Geng S; Guo Y; Wang Q; Li L; Wang J
Arch Dermatol Res; 2013 Jan; 305(1):35-47. PubMed ID: 22740085
[TBL] [Abstract][Full Text] [Related]
6. Localization of CD44 and CD90 positive cells to the invasive front of breast tumors.
Donnenberg VS; Donnenberg AD; Zimmerlin L; Landreneau RJ; Bhargava R; Wetzel RA; Basse P; Brufsky AM
Cytometry B Clin Cytom; 2010 Sep; 78(5):287-301. PubMed ID: 20533389
[TBL] [Abstract][Full Text] [Related]
7. Lung cancer tumorigenicity and drug resistance are maintained through ALDH(hi)CD44(hi) tumor initiating cells.
Liu J; Xiao Z; Wong SK; Tin VP; Ho KY; Wang J; Sham MH; Wong MP
Oncotarget; 2013 Oct; 4(10):1698-1711. PubMed ID: 24091605
[TBL] [Abstract][Full Text] [Related]
8. The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44.
Liu C; Kelnar K; Liu B; Chen X; Calhoun-Davis T; Li H; Patrawala L; Yan H; Jeter C; Honorio S; Wiggins JF; Bader AG; Fagin R; Brown D; Tang DG
Nat Med; 2011 Feb; 17(2):211-5. PubMed ID: 21240262
[TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of cells with cancer stem cell properties in human primary lung cancer cell lines.
Wang P; Gao Q; Suo Z; Munthe E; Solberg S; Ma L; Wang M; Westerdaal NA; Kvalheim G; Gaudernack G
PLoS One; 2013; 8(3):e57020. PubMed ID: 23469181
[TBL] [Abstract][Full Text] [Related]
10. Preferential histiotypic expression of CD44-isoforms in human lung cancer.
Wimmel A; Schilli M; Kaiser U; Havemann K; Ramaswamy A; Branscheid D; Kogan E; Schuermann M
Lung Cancer; 1997 Mar; 16(2-3):151-72. PubMed ID: 9152947
[TBL] [Abstract][Full Text] [Related]
11. The malignant pleural effusion as a model to investigate intratumoral heterogeneity in lung cancer.
Basak SK; Veena MS; Oh S; Huang G; Srivatsan E; Huang M; Sharma S; Batra RK
PLoS One; 2009 Jun; 4(6):e5884. PubMed ID: 19536353
[TBL] [Abstract][Full Text] [Related]
12. ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinoma.
Kim MP; Fleming JB; Wang H; Abbruzzese JL; Choi W; Kopetz S; McConkey DJ; Evans DB; Gallick GE
PLoS One; 2011; 6(6):e20636. PubMed ID: 21695188
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-34a suppresses invasion and metastatic in esophageal squamous cell carcinoma by regulating CD44.
Zuo J; Zhu K; Wang Y; Yu Z
Mol Cell Biochem; 2018 Jun; 443(1-2):139-149. PubMed ID: 29094237
[TBL] [Abstract][Full Text] [Related]
14. Replication Study: The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44.
Yan X; Tang B; Chen B; Shan Y; Yang H;
Elife; 2019 Mar; 8():. PubMed ID: 30860027
[TBL] [Abstract][Full Text] [Related]
15. MiR-199a-5p represses the stemness of cutaneous squamous cell carcinoma stem cells by targeting Sirt1 and CD44ICD cleavage signaling.
Lu RH; Xiao ZQ; Zhou JD; Yin CQ; Chen ZZ; Tang FJ; Wang SH
Cell Cycle; 2020 Jan; 19(1):1-14. PubMed ID: 31809227
[TBL] [Abstract][Full Text] [Related]
16. Non-small cell lung cancer cells expressing CD44 are enriched for stem cell-like properties.
Leung EL; Fiscus RR; Tung JW; Tin VP; Cheng LC; Sihoe AD; Fink LM; Ma Y; Wong MP
PLoS One; 2010 Nov; 5(11):e14062. PubMed ID: 21124918
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-34a regulates epithelial-mesenchymal transition and cancer stem cell phenotype of head and neck squamous cell carcinoma in vitro.
Sun Z; Hu W; Xu J; Kaufmann AM; Albers AE
Int J Oncol; 2015 Oct; 47(4):1339-50. PubMed ID: 26323460
[TBL] [Abstract][Full Text] [Related]
18. SMURF1 silencing diminishes a CD44-high cancer stem cell-like population in head and neck squamous cell carcinoma.
Khammanivong A; Gopalakrishnan R; Dickerson EB
Mol Cancer; 2014 Dec; 13():260. PubMed ID: 25471937
[TBL] [Abstract][Full Text] [Related]
19. EGCG inhibits CSC-like properties through targeting miR-485/CD44 axis in A549-cisplatin resistant cells.
Jiang P; Xu C; Chen L; Chen A; Wu X; Zhou M; Haq IU; Mariyam Z; Feng Q
Mol Carcinog; 2018 Dec; 57(12):1835-1844. PubMed ID: 30182373
[TBL] [Abstract][Full Text] [Related]
20. Nanovesicle-mediated systemic delivery of microRNA-34a for CD44 overexpressing gastric cancer stem cell therapy.
Jang E; Kim E; Son HY; Lim EK; Lee H; Choi Y; Park K; Han S; Suh JS; Huh YM; Haam S
Biomaterials; 2016 Oct; 105():12-24. PubMed ID: 27497057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]